Riskpilot← Back to searchSign inGet full accessBioservo AB
ABActiveOrg 5594682253Torshamnsgatan 35Engineering activities and related technical consultancy · NACE 7112Est. 20245-9 employees
Revenue 2024
SEK 12M
EBITDA margin
-112.6%
Equity ratio
49.3%
Financial strength
Net profit 2024
SEK -13,6M
| Revenue | SEK 12M | — |
| EBITDA | SEK -13,5M | — |
| Net profit | SEK -13,6M | — |
| Total assets | SEK 11,1M | — |
| Equity | SEK 5,5M | — |
| Employees | — | — |
Legal name
Bioservo AB
Org number
5594682253
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
16 januari 2024
Share capital
SEK 100 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva forskning, utveckling, tillverkning och försäljning av bärbar robotik för tillämpning inom industri och medicinsk teknik, utföra teknisk konsultverksamhet samt därmed förenlig verksamhet.
Address
Torshamnsgatan 35
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 |
|---|---|
| Revenue | 11 979 |
| Staff expenses | −10 428 |
| EBITDA | −13 493 |
| Depreciation & amort. | −79 |
| EBIT | −13 573 |
| Net financials | −40 |
| Profit before tax | −13 613 |
| Tax | — |
| Net profit | −13 613 |
| Item | 2024 |
|---|---|
| Total assets | 11 133 |
| Equity | 5 487 |
| Long-term debt | — |
| Short-term debt | 5 646 |
| Total debt | 5 646 |
EBITDA margin
-112.6%
This company
15.8%
Market median
-813% vs market
20242024
Equity ratio
49.3%
This company
38.2%
Market median
+29% vs market
20242024
Return on equity
-248.1%
This company
18.4%
Market median
-1448% vs market
20242024
Net profit margin
-113.6%
This company
8.1%
Market median
-1502% vs market
20242024
Asset turnover
1.08×
This company
1.12×
Market median
+4% vs market
20242024
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20242024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-16 – 2024-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SP Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
BN Chief Auditor | Chief Auditor | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Chairman | 2024 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Servacq AB | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Servacq AB
Bioservo AB Board members of Bioservo AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sten Petter Anders Bäckgren | Chief Executive Officer | 0 companies |
| Bengt Nils Martin Holm | Chief Auditor | 0 companies |
| Nils Johan Prytz | Board of Directors | 0 companies |
| Carl Philip Anders Franzén | Deputy Board Member | 0 companies |
| Bengt Håkan Englund | Chairman | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Erik Alexander Stötsberg | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |